Adding a novel anti-GD2 antibody (hu14.18K322A) to induction chemotherapy for children with newly diagnosed high-risk neuroblastoma ...

Two new Yale-led studies elucidate protein structure and function of ALK, a protein receptor, which could contribute to new treatments...

In mice with high-risk neuroblastoma, tumors disappeared in response to a new combination treatment with precision medicines, a recent...

St. Jude Children's Research Hospital scientists looking for drugs to improve survival of children with high-risk neuroblastoma found a ...

In a recent study published in the Journal for ImmunoTherapy of Cancer, a team of physician-scientists from the University of Chicago...

There is a real need for more tailored therapies for young people with cancer. For this year’s Childhood Cancer Awareness Month,...

Researchers at UCL have developed a new way to deliver drugs that can shut down cancer-promoting mutations in neuroblastoma. The...

Now researchers in the Feng lab at Boston University School of Medicine (BUSM), in collaboration with scientists in the Simon lab at ...

Researchers at Baylor College of Medicine and Texas Children’s Cancer Center have found that the molecular clock may be key to treating ...

The initial chemotherapy of aggressive childhood nerve tumors, so-called high-risk neuroblastomas, is crucial for ultimate survival. It...